Fig. 1From: Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trialCONSORT diagram showing flow of patients through the ZEBRA 1 sub-study. The diagram provides a summary of the flow of patients through the ZEBRA 1 sub-study including screened cases and 13 patients randomisedBack to article page